HYK华因康品牌怎么样 申请店铺

我要投票 HYK华因康在基因检测行业中的票数:5 更新时间:2024-11-21
HYK华因康是哪个国家的品牌?「HYK华因康」是 深圳华因康基因科技有限公司 旗下著名品牌。该品牌发源于广东,由创始人盛司在2008-01-23期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
HYK华因康怎么样

华因康集团秉承“专业、严谨、创新、服务”的理念,自2008年创立以来,一直致力于中华民族健康事业,发展迅猛。迄今拥有深圳市华因康高通量生物技术研究院、深圳华因康基因科技有限公司、华因康基因检测中心及全国各地多家分支机构,成为以基因技术为核心,拥有雄厚研发支撑、具备研发、生产和应用三位一体的完整产业链的生物技术高科技集团。

研发中心–深圳市华因康高通量生物技术研究院拥有一支在机械、光学、电子、生化、软件、生物信息、生物医疗等技术领域具备尖端技术成果的科学家、教授、博士、博士后及行业专家组成的精英技术团队。研究院面向世界科学前沿和国家战略发展需求,以新型DNA测序分析技术的突破为契机,旨在研究高通量生物技术,开发高通量实验和检测设备,寻找高通量检测新方法,为我国生命科技领域的上游进行产业布局,搭建与基因技术相关的生命科技产业基础性研究平台,进行国际前沿基因组科学基础及应用研究与技术开发,提升我国基因技术自主创新能力。

产品中心-深圳华因康基因科技有限公司专业生产、销售高通量基因测序设备、生物试剂和基因信息分析软件,提供科研技术服务与生物信息数据分析技术服务。公司主导产品PSTAR高通量基因测序系统,填补了我国在生命科技产业核心装备、基因测序设备制造、试剂生产与生物信息分析服务等领域的空白,广泛应用于生命科学基础研究、临床诊断与治疗、疾病预防与保健以及新药研制等领域。

基因检测中心-华因康基因检测中心依托于华因康基因新一代高通量基因测序系统平台技术,是转化医学的专业化服务机构。中心以新一代高通量基因测序系统技术平台为核心,辅以实时荧光PCR平台、STR分析平台、免疫组化、荧光原位杂交等技术平台,覆盖了DNA、RNA、蛋白水平,测序、PCR、蛋白免疫组化、FISH等多种检测技术。已率先研发出多种适用于亚洲人的临床基因检测项目,专业提供“肿瘤个体化用药指导靶基因检测”临床技术服务,同时为临床提供疾病早期筛查、重大疾病分子标志物检测及与保健、优生优育相关的检测服务。与国内顶级医院及科研机构携手,开拓高通量基因测序技术在生命科学与医疗健康领域中的广阔应用,为人类的健康事业提供专业、贴心的个性化服务。

华因康基因(集团)将始终坚持“探索基因信息,提高生命价值”的宗旨,致力于打造基因生命科技在研发、应用、临床转化系统平台技术上的核心竞争力,彰显中国基因产业在世界竞争中的领航者地位,引领中国健康产业发展新方向。


Huayinkang group adheres to the concept of "professional, rigorous, innovative and service". Since its establishment in 2008, it has been committed to the cause of health of the Chinese nation, with rapid development. So far, it has Shenzhen huayinkang high throughput Biotechnology Research Institute, Shenzhen huayinkang Gene Technology Co., Ltd., huayinkang gene testing center and many branches all over the country. It has become a biotechnology high-tech group with gene technology as the core, strong R & D support, and a complete industrial chain of R & D, production and application. R & D Center - Shenzhen huayinkang high throughput Biotechnology Research Institute has an elite technical team composed of scientists, professors, doctors, postdoctors and industry experts with cutting-edge technical achievements in the fields of machinery, optics, electronics, biochemistry, software, biological information, biomedicine and other technical fields. Facing the needs of the world's scientific frontier and national strategic development, and taking the breakthrough of new DNA sequencing analysis technology as an opportunity, the research institute aims to study high-throughput biotechnology, develop high-throughput experiment and detection equipment, find new high-throughput detection methods, make industrial layout for the upstream of China's life science and technology field, and build a basic research platform of life science and technology industry related to gene technology To carry out basic and applied research and technological development of international frontier genomic science and improve the independent innovation ability of China's gene technology. Product Center - Shenzhen huayinkang Gene Technology Co., Ltd. specializes in the production and sales of high-throughput gene sequencing equipment, biological reagents and gene information analysis software, providing scientific research and technical services and biological information data analysis technical services. The company's leading product, pstar high-throughput gene sequencing system, has filled in the gaps in the core equipment of life science and technology industry, gene sequencing equipment manufacturing, reagent production and bio information analysis services in China, and is widely used in basic research of life science, clinical diagnosis and treatment, disease prevention and health care, and new drug development and other fields. Based on the platform technology of new generation high-throughput gene sequencing system of huayinkang gene, huayinkang gene testing center is a professional transformation medicine service organization. The center takes the new generation high-throughput gene sequencing system technology platform as the core, supplemented by real-time fluorescent PCR platform, STR analysis platform, immunohistochemistry, fluorescence in situ hybridization and other technology platforms, covering DNA, RNA, protein level, sequencing, PCR, protein immunohistochemistry, fish and other detection technologies. It has taken the lead in developing a variety of clinical gene detection projects suitable for Asians, providing professional clinical technical services of "tumor individualized drug use guidance target gene detection", and providing early disease screening, detection of major disease molecular markers and detection services related to health care, eugenics and eugenics. Together with the top domestic hospitals and scientific research institutions, we will explore the wide application of high-throughput gene sequencing technology in the field of life science and medical health, and provide professional and intimate personalized services for human health. Huayinkang gene (Group) will always adhere to the tenet of "exploring gene information and improving life value", devote itself to building the core competitiveness of gene life technology in research and development, application and clinical transformation system platform technology, highlight the leading position of China's gene industry in the world competition, and lead the new development direction of China's health industry.

本文链接: https://brand.waitui.com/4c1ad289a.html 联系电话:075526611270

千城特选小程序码

7×24h 快讯

国资委:目前最紧迫的是要向前瞻性战略性新兴产业集中

36氪获悉,据国务院国资委官网,11月19日至20日,国务院国资委党委举办理论学习中心组集体学习会暨厅局级干部研修班。大家一致认为,要完善国有经济布局优化和结构调整机制,推动中央企业加快构建现代化产业体系。要谋划好国资央企“十五五”规划,把行业研究透、家底理清楚,科学严谨、能够落地。要更加有效推进国有资本“三个集中”,目前最紧迫的是要向前瞻性战略性新兴产业集中,在维护国家国防安全、粮食安全、能源安全等方面发挥战略安全兜底作用,深入推进战略性、专业化重组。

2小时前

人民银行科技司:正在加紧出台金融业数据跨境流动合规指南

在11月21日2024年世界互联网大会乌镇峰会“数据治理论坛”上,中国人民银行科技司司长李伟介绍,年初,在国家网信部门统筹指导下,人民银行会同其他金融管理部门开展研究,编制了《促进和规范金融业数据跨境流动合规指南》。目前,《指南》正在加紧出台中。《指南》明确,不含金融重要数据或个人信息的数据,在履行法律规定等一般性合规义务,以及满足国家网信部门、金融管理部门有关规定的前提下,可以自由跨境流动,自主向境外提供。(中证报)

2小时前

搜狗输入法打造全新AI搜索体验,输入即搜索

36氪获悉,11月21日,腾讯搜狗输入法进行全新升级,在腾讯混元大模型技术的支持下,推出和升级AI搜索、AI快查等重要功能,实现“输入即搜索”,在学习、办公、社交等场景中,做到边聊边搜、边写边搜,智能化提供参考信息。更重要的是,用户将可免费使用全部AI服务。

2小时前

阿里巴巴整合国内和海外电商,成立电商事业群,由蒋凡担任CEO

36氪独家获悉,11月21日,阿里巴巴集团CEO吴泳铭发布内部邮件,宣布整合国内和海外电商,成立电商事业群,由蒋凡担任CEO,向吴泳铭汇报。据了解,新的电商事业群将全面整合淘宝天猫集团、国际数字商业集团以及1688、闲鱼等电商业务,形成覆盖国内外全产业链的业务集群。信中表示,“通过整合集团内的所有电商资源,激发多年沉淀的能力,服务好国内和全球消费者,同时帮助更多中小企业同步拓展国内及海外市场。”

2小时前

快手-W获南向资金净买入7亿港元

南向资金今日净买入46.66亿元。港股通(沪)方面,快手-W、阿里巴巴-W分别获净买入7.0亿港元、1.4亿港元;小米集团-W净卖出额居首,金额为2.04亿港元;港股通(深)方面,阿里巴巴-W、小米集团-W分别获净买入2.83亿港元、1.84亿港元;融创中国净卖出额居首,金额为0.77亿港元。(第一财经)

2小时前

本页详细列出关于瑞博Ribo的品牌信息,含品牌所属公司介绍,瑞博Ribo所处行业的品牌地位及优势。
咨询